They've consistently beaten the market in recent years and they're still growing.
News & Analysis: Eli Lilly and Company
LLY earnings call for the period ending December 31, 2020.
Results of a clinical trial suggest pre-emptive treatment with bamlanivimab can prevent COVID-19 from spreading through nursing homes.
Investors can buy and hold these stocks without losing sleep at night.
Investors are cheering Lilly's update in Alzheimer's disease today.
The big drugmaker upped its guidance for this year and announced a bullish outlook for 2021.
The buyer is also on the hook for a milestone payment that could hit $4 per share.
The company's new payout will be dispensed in March.
Hot initial public offerings aren't just for technology companies.
The company released positive results from a pivotal clinical trial.